Grace Therapeutics Stock Market Value
| GRCE Stock | 3.63 0.03 0.83% |
| Symbol | Grace |
Will Pharmaceuticals sector continue expanding? Could Grace diversify its offerings? Factors like these will boost the valuation of Grace Therapeutics. Market participants price Grace higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Grace Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Grace Therapeutics requires distinguishing between market price and book value, where the latter reflects Grace's accounting equity. The concept of intrinsic value - what Grace Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Grace Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Grace Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Grace Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Grace Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Grace Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Grace Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Grace Therapeutics.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Grace Therapeutics on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Grace Therapeutics or generate 0.0% return on investment in Grace Therapeutics over 90 days. Grace Therapeutics is related to or competes with Cencora, Regeneron Pharmaceuticals, IDEXX Laboratories, Haleon Plc, Cigna Corp, Elevance Health, and Becton Dickinson. Grace Therapeutics is entity of United States More
Grace Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Grace Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Grace Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.34 | |||
| Information Ratio | 0.0732 | |||
| Maximum Drawdown | 12.43 | |||
| Value At Risk | (2.89) | |||
| Potential Upside | 3.8 |
Grace Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Grace Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Grace Therapeutics' standard deviation. In reality, there are many statistical measures that can use Grace Therapeutics historical prices to predict the future Grace Therapeutics' volatility.| Risk Adjusted Performance | 0.0986 | |||
| Jensen Alpha | 0.2337 | |||
| Total Risk Alpha | 9.0E-4 | |||
| Sortino Ratio | 0.0742 | |||
| Treynor Ratio | 0.8185 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Grace Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Grace Therapeutics February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0986 | |||
| Market Risk Adjusted Performance | 0.8285 | |||
| Mean Deviation | 1.84 | |||
| Semi Deviation | 2.02 | |||
| Downside Deviation | 2.34 | |||
| Coefficient Of Variation | 871.77 | |||
| Standard Deviation | 2.37 | |||
| Variance | 5.62 | |||
| Information Ratio | 0.0732 | |||
| Jensen Alpha | 0.2337 | |||
| Total Risk Alpha | 9.0E-4 | |||
| Sortino Ratio | 0.0742 | |||
| Treynor Ratio | 0.8185 | |||
| Maximum Drawdown | 12.43 | |||
| Value At Risk | (2.89) | |||
| Potential Upside | 3.8 | |||
| Downside Variance | 5.48 | |||
| Semi Variance | 4.07 | |||
| Expected Short fall | (2.17) | |||
| Skewness | (0.08) | |||
| Kurtosis | 0.4199 |
Grace Therapeutics Backtested Returns
Grace Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Grace Therapeutics holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14 % return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for Grace Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Grace Therapeutics' market risk adjusted performance of 0.8285, and Risk Adjusted Performance of 0.0986 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Grace Therapeutics holds a performance score of 10. The company retains a Market Volatility (i.e., Beta) of 0.32, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Grace Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Grace Therapeutics is expected to be smaller as well. Please check Grace Therapeutics' sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to make a quick decision on whether Grace Therapeutics' current trending patterns will revert.
Auto-correlation | 0.34 |
Below average predictability
Grace Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Grace Therapeutics time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Grace Therapeutics price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current Grace Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Grace Therapeutics is a strong investment it is important to analyze Grace Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Grace Therapeutics' future performance. For an informed investment choice regarding Grace Stock, refer to the following important reports:Check out Grace Therapeutics Correlation, Grace Therapeutics Volatility and Grace Therapeutics Performance module to complement your research on Grace Therapeutics. For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Grace Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.